Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancer
Kenichi Suda, Isao Murakami, Keiko Obata, Kazuko Sakai, Toshio Fujino, T. Koga, Shuta Ohara, Akira Hamada, Junichi Soh, Kazuto Nishio, Tetsuya Mitsudomi
Topics & Concepts
MedicineLung cancerTyrosine kinaseCancer researchAcquired resistanceCancerOncologyInternal medicineReceptorLung Cancer Treatments and MutationsMelanoma and MAPK PathwaysFibroblast Growth Factor Research